BamSEC and AlphaSense Join Forces
Learn More

Sonnet BioTherapeutics Holdings Inc.

NASDAQ: SONN    
Share price (12/24/24): $1.42    
Market cap (12/24/24): $4.271 million
Search in Documents
Key Exhibits
External Links

Underwriting Agreements Filter

EX-1.1
from 8-K 62 pages Sonnet BioTherapeutics Holdings, Inc. Underwriting Agreement
12/34/56
EX-1.1
from S-1/A 62 pages Sonnet BioTherapeutics Holdings, Inc. Underwriting Agreement
12/34/56
EX-1.1
from S-1/A 61 pages Sonnet BioTherapeutics Holdings, Inc. Underwriting Agreement
12/34/56
EX-1.1
from S-1/A 61 pages Sonnet BioTherapeutics Holdings, Inc. Underwriting Agreement
12/34/56
EX-1.1
from 8-K 60 pages 13,888,888 Shares of Common Stock (Or Pre-Funded Warrants to Purchase Shares of Common Stock in Lieu Thereof) Warrants to Purchase 27,777,776 Shares of Common Stock Sonnet BioTherapeutics Holdings, Inc. Underwriting Agreement
12/34/56
EX-1.1
from S-1/A 62 pages [•] Shares of Common Stock (Or Pre-Funded Warrants to Purchase Shares of Common Stock in Lieu Thereof) Warrants to Purchase [●] Shares of Common Stock Sonnet BioTherapeutics Holdings, Inc. Underwriting Agreement
12/34/56
EX-1.1
from S-1/A 63 pages [•] Shares of Common Stock (Or Pre-Funded Warrants to Purchase Shares of Common Stock in Lieu Thereof) Warrants to Purchase [●] Shares of Common Stock Sonnet BioTherapeutics Holdings, Inc. Underwriting Agreement
12/34/56
EX-1.1
from 8-K 47 pages Sonnet BioTherapeutics Holdings, Inc. Up to $25,000,000 of Common Stock (Par Value $0.0001 Per Share) At-The-Market Sales Agreement
12/34/56
EX-1.1
from S-1/A 84 pages [•] Shares of Common Stock (Or Pre-Funded Warrants to Purchase Shares of Common Stock in Lieu Thereof) Warrants to Purchase [●] Shares of Common Stock Sonnet BioTherapeutics Holdings, Inc. Underwriting Agreement
12/34/56
EX-1.1
from S-1/A 65 pages [•] Shares of Common Stock (Or Pre-Funded Warrants to Purchase Shares of Common Stock in Lieu Thereof) Sonnet BioTherapeutics Holdings, Inc. Underwriting Agreement
12/34/56
EX-1
from SC 13G/A 1 page Exhibit 1 Joint Acquisition Statement Pursuant to Section 240.13d-1
12/34/56
EX-1.1
from 8-K 51 pages Sonnet BioTherapeutics Holdings, Inc. Up to $15,875,000 of Common Stock (Par Value $0.0001 Per Share) At-The-Market Sales Agreement
12/34/56
EX-1
from SC 13D ~5 pages Joint Filing Agreement
12/34/56
EX-1.0
from S-1/A 32 pages Form of Dealer-Manager Agreement
12/34/56
EX-1
from S-1/A 10 pages Source Capital Group, Inc. Proposed Offering Engagement Letter
12/34/56
EX-1.0
from S-1 11 pages Subject to Approval by Source Capital Group Legal & Due Diligence Completion
12/34/56
EX-1.1
from 8-K 40 pages Chanticleer Holdings, Inc. 2,444,450 Units Underwriting Agreement
12/34/56
EX-1.1
from S-1/A 33 pages Chanticleer Holdings, Inc. 2,500,000 Units Underwriting Agreement
12/34/56
EX-1.1
from S-1/A 33 pages Chanticleer Holdings, Inc. 2,500,000 Units Underwriting Agreement
12/34/56
EX-1.1
from S-1/A 33 pages Chanticleer Holdings, Inc. 5,000,000 Units Underwriting Agreement
12/34/56